Plasma rich in growth factors in alveolar ridge preservation: randomized, controlled clinical trial

PURPOSE: The objective of this study is to evaluate the efficacy of Plasma rich in growth factors (PRGF) compared to spontaneous healing in alveolar ridge preservation of the aesthetic zone. METHODS: This randomized and controlled clinical trial included 46 patients requiring simple-tooth extraction in the aesthetic zone and subsequent implant placement. The extraction sockets were treated either with PRGF or allowed to heal spontaneously. Postoperative healing was assessed by pain, Landry's soft tissue healing index, and inflammation index at 3, 7, and 15 days after tooth extraction. Histomorphometric bone regeneration was evaluated in biopsies harvested after 12 weeks of healing. Dimensional alveolar ridge measurements were performed at baseline and 12 weeks. Any postoperative complications and adverse effects were registered. Statistical analysis was performed to assess the differences between the study groups. RESULTS: PRGF significantly enhanced postoperative healing, as evidenced by statistically significant reductions in pain on day 3 (p = 0.036) and improved soft tissue healing on days 3 (p = 0.047), 5 (p = 0.012), and 7 (p = 0.027). No significant differences were observed between groups regarding postoperative inflammation. The new bone formation was significantly improved with PRGF treatment (p = 0.024), with a median of 36.1% (range: 15.8% to 58.9%) in the control group compared to 48.7% (range: 31.9% to 92.3%) in the PRGF group. PRGF contributed to improved dimensional stability of the alveolar ridge at 12 weeks. CONCLUSION: PRGF improved healing following tooth extraction by promoting soft tissue healing and reducing postoperative pain. Additionally, it enhanced bone regeneration and contributed to better preservation of the alveolar ridge.

— actualidad · noticias ›

BTI Biotechnology Institute supera una década de liderazgo científico entre las bioempresas españolas

miércoles, 10 de junio de 2026

BTI Biotechnology Institute vuelve a situarse como la empresa biotecnológica española con mayor producción científica, con un total de 29 publicaciones recogidas en el Informe AseBio 2025.

Clin Oral Investig

2,026

Autores:
Eduardo Anitua Aldecoa

PURPOSE: The objective of this study is to evaluate the efficacy of Plasma rich in growth factors (PRGF) compared to spontaneous healing in alveolar ridge preservation of the aesthetic zone. METHODS: This randomized and controlled clinical trial included 46 patients requiring simple-tooth extraction in the aesthetic zone and subsequent implant placement. The extraction sockets were treated either with PRGF or allowed to heal spontaneously. Postoperative healing was assessed by pain, Landry's soft tissue healing index, and inflammation index at 3, 7, and 15 days after tooth extraction. Histomorphometric bone regeneration was evaluated in biopsies harvested after 12 weeks of healing. Dimensional alveolar ridge measurements were performed at baseline and 12 weeks. Any postoperative complications and adverse effects were registered. Statistical analysis was performed to assess the differences between the study groups. RESULTS: PRGF significantly enhanced postoperative healing, as evidenced by statistically significant reductions in pain on day 3 (p = 0.036) and improved soft tissue healing on days 3 (p = 0.047), 5 (p = 0.012), and 7 (p = 0.027). No significant differences were observed between groups regarding postoperative inflammation. The new bone formation was significantly improved with PRGF treatment (p = 0.024), with a median of 36.1% (range: 15.8% to 58.9%) in the control group compared to 48.7% (range: 31.9% to 92.3%) in the PRGF group. PRGF contributed to improved dimensional stability of the alveolar ridge at 12 weeks. CONCLUSION: PRGF improved healing following tooth extraction by promoting soft tissue healing and reducing postoperative pain. Additionally, it enhanced bone regeneration and contributed to better preservation of the alveolar ridge.

Artículos relacionados

Continúa tu investigación a través de nuestra selección de publicaciones vinculadas. Descubre estudios complementarios que abordan áreas temáticas, enfoques clínicos o desarrollos afines, diseñados para enriquecer tu comprensión sobre este campo científico.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

Contacta

Gros plan
Nombre *

Apellidos *

Correo electrónico *

¿Cómo quieres que contactemos contigo? *

Teléfono *

Código postal *

País *

Escribe aquí tu consulta *